OC
BCTF

Oppenheimer & Close’s Bancorp 34, Inc. Common Stock BCTF Stock Holding History

Oppenheimer & Close’s Portfolio BCTF Stock Details BCTF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-26,300
Closed -$331K – 41
2016
Q4 		$331K Buy
+26,300
New +$329K 0.3% 36

Other funds holding BCTF

SV
Stilwell Value New York $167M AUM 3.79% 1-Year Est. Return
LBS
Lawrence B. Seidman $79.8M AUM 15.9% 1-Year Est. Return
MCM
Maltese Capital Management New York $508M AUM 21.31% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
EM
ELCO Management New York $208M AUM 23.85% 1-Year Est. Return
MCA
Mendon Capital Advisors Key Largo, Florida $258M AUM 21.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DMK
David M. Knott $275M AUM 59.23% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Oppenheimer & Close's BCTF Position: Q1 2017 in Review

Oppenheimer & Close sold out of Bancorp 34, Inc. Common Stock (BCTF) in Q1 2017, closing a stake of 26,300 shares — an estimated $331K sold.

Oppenheimer & Close first reported a position in BCTF in Q4 2016 and held it in 1 quarter. The position peaked at $331K in Q4 2016. 10 funds tracked by Wall St. Rank hold BCTF as of Q1 2017.

  • Oppenheimer & Close reported no remaining Bancorp 34, Inc. Common Stock position as of Q1 2017 after selling out during the quarter.
  • Oppenheimer & Close sold 26,300 Bancorp 34, Inc. Common Stock shares in Q1 2017, an estimated $331K.
  • Oppenheimer & Close first reported a position in Bancorp 34, Inc. Common Stock in Q4 2016 and held it in 1 quarter.
  • Oppenheimer & Close's Bancorp 34, Inc. Common Stock position peaked at $331K in Q4 2016.
  • 10 funds tracked by Wall St. Rank held Bancorp 34, Inc. Common Stock as of Q1 2017.

Based on Oppenheimer & Close's 13F filing for Q1 2017, filed 12 May 2017.